Paired with Stelo by Dexcom and the Signos AI platform, patients see the metabolic consequences of their choices in real time: For patients with PCOS, perimenopause, prediabetes, insulin resistance, or post-GLP-1 weight maintenance needs, Signos turns invisible metabolic dysfunction into legible, actionable data
FAT/CD36: a major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice
The actual infusion time takes about 30-45 minutes this is your chance to relax, catch up on emails, read a book, or just enjoy some peaceful downtime
Think of it this way: semaglutide pulls one lever to help you lose weight, tirzepatide pulls two, and retatrutide pulls three
At Excel Medicine, were noticing the same trend: patients are feeling their way toward individualized dosing long before the data exists to support it